Washington, United States,
08048034981

Fulvestrant (250mg)

Fulvenat 250 Mg Injection

In stock

Description

Fulvenat 250mg Injection (fulvestrant), a selective estrogen receptor antagonist used for the treatment and management of hormone receptor-positive breast cancer in postmenopausal women. It works by blocking the action of estrogen on cancer cells, thereby slowing or stopping their growth. This medicine is administered as an intramuscular injection by a trained healthcare professional.

Specifications

Strength250mg/Vial
Pack Size250mg / Vial
UsesHormone-receptor-positive breast cancer
Main IngredientsFulvestrant (250mg)
Route of Administration Intramuscular
Storage refrigerator (2°C to 8°C)